| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/05/2015 | WO2015031722A1 Method for treating amyotrophic lateral sclerosis by inhibition of cxcr4/cxcl12 signaling |
| 03/05/2015 | WO2015031493A1 Amino acid treatment of seizures |
| 03/05/2015 | WO2015031392A1 Products and methods for treatment of amyotrophic lateral sclerosis |
| 03/05/2015 | WO2015029968A1 Clock gene expression level modifier |
| 03/05/2015 | WO2015029169A1 Javanese ginger extract and method for producing same |
| 03/05/2015 | WO2015028848A1 Bicyclic heterocyclic compounds as multi-kinase inhibitors |
| 03/05/2015 | WO2015028673A1 Cav3 CHANNEL BLOCKING AGENT FOR PAIN TREATMENT |
| 03/05/2015 | WO2015028659A1 Composition comprising torasemide and baclofen for treating neurological disorders |
| 03/05/2015 | WO2015028483A1 Pyrrolopyridine or pyrazolopyridine derivatives |
| 03/05/2015 | WO2015028409A1 6,7-dihydro-5h-benzo[7]annulene derivatives, method for the preparation thereof, pharmaceutical preparations comprising them, and the use thereof for producing medicaments |
| 03/05/2015 | WO2015027963A1 Aromatic ring derivative, and pharmaceutical composition and use thereof |
| 03/05/2015 | WO2015027959A1 Cyclic peptide compound, and preparation method, pharmaceutical composition and use thereof |
| 03/05/2015 | WO2015027949A1 Application of deuterated fumaric acid derivatives in treatment of multiple sclerosis |
| 03/05/2015 | WO2015027518A1 Chinese herbal medicine health-care cigarette |
| 03/05/2015 | WO2015027342A1 Microgel compositions for delivery of substances to the brain |
| 03/05/2015 | WO2015027307A1 Benzylthiazolidinone derivatives useful for the treatment of schizophrenia |
| 03/05/2015 | WO2015027296A1 A method of treatment |
| 03/05/2015 | WO2014210596A9 Treating an arrhythmia with an opioid antagonist |
| 03/05/2015 | DE102013014417A1 Schwammkollagen umfassende Zubereitungen mit definiertem in vivo-Freisetzungsprofil vor allem im Colon, deren Herstellung und Verwendung Collagen sponge comprehensive preparations defined in vivo release profile especially in the colon, their preparation and use |
| 03/04/2015 | EP2843049A1 Neuronal differentiation promoter |
| 03/04/2015 | EP2842969A1 Lactoferrin fusion protein and method for producing same |
| 03/04/2015 | EP2842967A1 Pegylated amyloid beta fab |
| 03/04/2015 | EP2842957A1 Method for extracting and separating ginkgolides |
| 03/04/2015 | EP2842955A1 Trk-INHIBITING COMPOUND |
| 03/04/2015 | EP2842942A1 Trans-2-decenoic acid derivative and drug containing same |
| 03/04/2015 | EP2842937A1 Amine compound and use thereof for medical purposes |
| 03/04/2015 | EP2842933A1 Mixtures of cannabinoid compounds, their preparation and use |
| 03/04/2015 | EP2842566A1 Use of arpin a new inhibitor of the arp2/3 complex for the diagnosis and treatment of diseases |
| 03/04/2015 | EP2842556A2 Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines |
| 03/04/2015 | EP2842549A1 Orally disintegrating tablet and method for producing same |
| 03/04/2015 | EP2841578A1 RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders |
| 03/04/2015 | EP2841438A1 Pantothenate derivatives for the treatment of neurologic disorders |
| 03/04/2015 | EP2841435A1 Pyrrolopyridinone derivatives as ttx-s blockers |
| 03/04/2015 | EP2841431A1 Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same |
| 03/04/2015 | EP2841421A1 Amide derivatives as ttx-s blockers |
| 03/04/2015 | EP2841418A1 (3,4-dichloro-phenyl)-((s)-3-propyl-pyrrolidin-3-yl)-methanone hydrochloride and manufacturing processes |
| 03/04/2015 | EP2841111A1 A nanosphere - histone acetyltransferase (hat) activator composition, process and methods thereof |
| 03/04/2015 | EP2841107A1 Cytotoxic-drug delivering molecules targeting hiv (cdm-hs), cytotoxic activity against the human immunodeficiency virus and methods of use |
| 03/04/2015 | EP2841089A1 Compositions, methods and assays comprising amylin or amlyin analogs for abeta-peptide mediated disorders |
| 03/04/2015 | EP2841072A1 Combination meloxicam and xylazine therapy in animals |
| 03/04/2015 | EP2841071A1 Formulations and methods for delaying onset of chronic neuropathic pain |
| 03/04/2015 | EP2841063A2 Compositions and methods for treating ptsd and related diseases |
| 03/04/2015 | EP2841060A1 Method of prevention of neurological diseases |
| 03/04/2015 | EP2841054A1 Injectable preparation |
| 03/03/2015 | US8969297 Methods and compositions for the induction of hypothermia |
| 03/03/2015 | US8968747 Injection paradigm for administration of botulinum toxins |
| 02/28/2015 | CA2825821A1 1-phenylalkanecarboxylic acid derivatives for the treatment of alzheimer's disease and multiple sclerosis |
| 02/26/2015 | WO2015027146A1 Inhibitors of human 12/15-lipoxygenase |
| 02/26/2015 | WO2015026574A1 Imidazopyridazine kinase inhibitors useful to treating a disease or disorder mediated by aak1, such as alzheimer's disease, bipolar disorder, pain, schizophrenia |
| 02/26/2015 | WO2015026339A1 Composition for reducing nervous system injury and method of making and use thereof |
| 02/26/2015 | WO2015026170A1 Indole compound as inhibitor of necrosis |
| 02/26/2015 | WO2015025995A1 Pharmaceutical composition and method for preventing or treating diseases associated with epilepsy or convulsions by targeting microrna |
| 02/26/2015 | WO2015025980A1 Method for treating neuropathic pain |
| 02/26/2015 | WO2015025902A1 Nasal brain function regulator and method for nasally regulating brain function |
| 02/26/2015 | WO2015025770A1 Method for screening pain inhibitor and medicinal composition for preventing or treating pain |
| 02/26/2015 | WO2015025718A1 Adhesive patch |
| 02/26/2015 | WO2015025323A1 Treatment of mood and stress related disorders |
| 02/26/2015 | WO2015025172A1 5-aryl-thiazol-2-yl-amine compounds and their therapeutic use |
| 02/26/2015 | WO2015024925A1 Modulators of the unconventional secretory pathway for use in the treatment of alexander disease |
| 02/26/2015 | WO2015024819A1 V1a antagonists to treat phase shift sleep disorders |
| 02/25/2015 | EP2839831A1 Modulators of the unconventional secretory pathway for use in the treatment of Alexander disease |
| 02/25/2015 | EP2838902A1 Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents |
| 02/25/2015 | EP2838888A1 Thiadiazolidinediones as gsk-3 inhibitors |
| 02/25/2015 | EP2838882A1 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 02/25/2015 | EP2838539A1 Estrogenic components for use in the treatment of neurological disorders. |
| 02/25/2015 | EP2838530A1 Methods for treating parkinson's disease |
| 02/25/2015 | EP2838517A1 Orally available pharmaceutical formulation suitable for improved management of movement disorders |
| 02/24/2015 | US8962834 Modulators of amyloid beta |
| 02/24/2015 | US8962639 Potassium channel modulators |
| 02/24/2015 | US8962613 P2X4 receptor antagonist |
| 02/24/2015 | US8962600 Neuroprotective compounds and their use |
| 02/24/2015 | US8962546 Modulation of estrogen receptor-related receptor gamma (ERRγ) and uses therefor |
| 02/24/2015 | US8962032 Modulator |
| 02/24/2015 | CA2804165C Piperidinyl pyrimidine amides as kv7 potassium channel openers |
| 02/24/2015 | CA2703915C P2x3 receptor antagonists for treatment of pain |
| 02/24/2015 | CA2679206C Pharmaceutical compositions comprising trigonelline and 4-hydroxyisoleucine and a process thereof |
| 02/24/2015 | CA2658633C Chiral compounds substituted with phosphonic acid ester functions or phosphonic acid functions |
| 02/24/2015 | CA2645120C Treatment of cns conditions |
| 02/24/2015 | CA2627423C Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors |
| 02/24/2015 | CA2585317C Drug combination for the treatment of depression and related disorders comprising a selective serotonin reuptake inhibitor |
| 02/19/2015 | WO2015023937A1 Heterochromatin forming non-coding rnas |
| 02/19/2015 | WO2015023901A1 Placenta-derived multipotent stem cells |
| 02/19/2015 | WO2015023890A1 Glycosylated pacap/vip analogues with enhanced cns penetration for treatment of neurodegenerative diseases |
| 02/19/2015 | WO2015023871A1 Treatment of alcoholism using ibudilast |
| 02/19/2015 | WO2015023816A1 (-)-(2r,3s)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (l)-(+) tartrate salt, its method of production and use |
| 02/19/2015 | WO2015023593A1 Progesterone phosphate analogs and uses related thereto |
| 02/19/2015 | WO2015023289A1 Substituted imidazoles as n-type calcium channel blockers |
| 02/19/2015 | WO2015023244A1 Drug with cerebro-protective effect |
| 02/19/2015 | WO2015023142A1 Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients |
| 02/19/2015 | WO2015023054A1 Animal model with obsessive compulsive disorder using ninjurin 1 deficiency |
| 02/19/2015 | WO2015022831A1 Composition for promoting estrogen and testosterone secretion, aromatic composition thereof, and aromatic tool thereof |
| 02/19/2015 | WO2015022830A1 Composition for promoting estrogen secretion, aromatic composition, and aroma tool |
| 02/19/2015 | WO2015022418A1 Treatment of cognitive impairment with pde4 inhibitor |
| 02/19/2015 | WO2015022417A1 Treatment of cognitive impairment with combination therapy |
| 02/19/2015 | WO2015022038A1 3-substituted cyclopentylamine derivatives |
| 02/19/2015 | WO2015021943A1 Inducing neurogenesis by axin enhancer |
| 02/19/2015 | WO2015021904A1 Method for synthesizing glatiramer acetate |
| 02/19/2015 | WO2015021535A1 Methods and uses of melatonin ligands |
| 02/19/2015 | WO2014190440A9 Abuse deterrent immediate release formulation |
| 02/18/2015 | EP2837623A1 Novel 1-substituted indazole derivative |